iTeos Therapeutics, Inc. (ITOS)
10.15
+0.02 (0.20%)
Inactive · Last trade price on Aug 28, 2025

iTeos Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for iTeos Therapeutics stock had an average target of $10.4, with a low estimate of $8.00 and a high estimate of $12.

Price Target: $10.4 (+2.46%)
Analyst Consensus: Hold

Price Target

TargetLowAverageMedianHigh
Price$8.00$10.4n/a$12
Change-21.18%+2.46%n/a+18.23%

Analyst Ratings

The average analyst rating for iTeos Therapeutics stock from 6 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
n/a
from 35.00M
Revenue Next Year
6.88M
EPS This Year
-3.58
from -3.32
EPS Next Year
-2.08
from -3.58
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-344.78M267.63M12.60M35.00M-6.88M
EPS
-2.885.682.56-3.15-3.32-3.58-2.08
No. Analysts
-----77

Revenue Forecast

Revenue20252026202720282029
Highn/a35.4M
Avgn/a6.9M
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-2.98-0.33
Avg-3.58-2.08
Low-4.39-3.45

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--